|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ausoni S, Boscolo-Rizzo P, Singh B, Da
Mosto MC, Spinato G, Tirelli G, Spinato R and Azzarello G:
Targeting cellular and molecular drivers of head and neck squamous
cell carcinoma: Current options and emerging perspectives. Cancer
Metastasis Rev. 35:413–426. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baxi S, Fury M, Ganly I, Rao S and Pfister
DG: Ten years of progress in head and neck cancers. J Natl Compr
Canc Netw. 10:806–810. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prince ME, Sivanandan R, Kaczorowski A,
Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles
LE: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Biddle A, Gammon L, Liang X, Costea DE and
Mackenzie IC: Phenotypic plasticity determines cancer stem cell
therapeutic resistance in oral squamous cell carcinoma.
EBioMedicine. 4:138–145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Z, Filho MS and Nör JE: The biology
of head and neck cancer stem cells. Oral Oncol. 48:1–9. 2012.
View Article : Google Scholar :
|
|
8
|
Johansson AC, La Fleur L, Melissaridou S
and Roberg K: The relationship between EMT, CD44high/EGFRlow
phenotype, and treatment response in head and neck cancer cell
lines. J Oral Pathol Med. 45:640–646. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Naik PP, Das DN, Panda PK, Mukhopadhyay S,
Sinha N, Praharaj PP, Agarwal R and Bhutia SK: Implications of
cancer stem cells in developing therapeutic resistance in oral
cancer. Oral Oncol. 62:122–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gemenetzidis E, Gammon L, Biddle A, Emich
H and Mackenzie IC: Invasive oral cancer stem cells display
resistance to ionising radiation. Oncotarget. 6:43964–43977. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bourguignon LY, Shiina M and Li JJ:
Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA
functions, chemoresistance, and radiation resistance in cancer stem
cells leading to tumor progression. Adv Cancer Res. 123:255–275.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Q, Shi S, Yen Y, Brown J, Ta JQ and
Le AD: A subpopulation of CD133(+) cancer stem-like cells
characterized in human oral squamous cell carcinoma confer
resistance to chemotherapy. Cancer Lett. 289:151–160. 2010.
View Article : Google Scholar
|
|
13
|
La Fleur L, Johansson AC and Roberg K: A
CD44high/EGFRlow subpopulation within head and neck cancer cell
lines shows an epithelial-mesenchymal transition phenotype and
resistance to treatment. PLoS One. 7:e440712012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Biddle A, Liang X, Gammon L, Fazil B,
Harper LJ, Emich H, Costea DE and Mackenzie IC: Cancer stem cells
in squamous cell carcinoma switch between two distinct phenotypes
that are preferentially migratory or proliferative. Cancer Res.
71:5317–5326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghuwalewala S, Ghatak D, Das P, Dey S,
Sarkar S, Alam N, Panda CK and Roychoudhury S: CD44(high)CD24(low)
molecular signature determines the cancer stem cell and EMT
phenotype in oral squamous cell carcinoma. Stem Cell Res (Amst).
16:405–417. 2016. View Article : Google Scholar
|
|
16
|
Seino S, Shigeishi H, Hashikata M,
Higashikawa K, Tobiume K, Uetsuki R, Ishida Y, Sasaki K, Naruse T,
Rahman MZ, et al: CD44(high)/ALDH1(high) head and neck squamous
cell carcinoma cells exhibit mesenchymal characteristics and
GSK3β-dependent cancer stem cell properties. J Oral Pathol Med.
45:180–188. 2016. View Article : Google Scholar
|
|
17
|
Takebe N, Miele L, Harris PJ, Jeong W,
Bando H, Kahn M, Yang SX and Ivy SP: Targeting Notch, Hedgehog, and
Wnt pathways in cancer stem cells: Clinical update. Nat Rev Clin
Oncol. 12:445–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kasper M, Schnidar H, Neill GW, Hanneder
M, Klingler S, Blaas L, Schmid C, Hauser-Kronberger C, Regl G,
Philpott MP, et al: Selective modulation of Hedgehog/GLI target
gene expression by epidermal growth factor signaling in human
keratinocytes. Mol Cell Biol. 26:6283–6298. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pak E and Segal RA: Hedgehog signal
transduction: Key players, oncogenic drivers, and cancer therapy.
Dev Cell. 38:333–344. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu J, Zeng H and Liu A: The loss of Hh
responsiveness by a non-ciliary Gli2 variant. Development.
142:1651–1660. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi X, Zhang Z, Zhan X, Cao M, Satoh T,
Akira S, Shpargel K, Magnuson T, Li Q, Wang R, et al: An epigenetic
switch induced by Shh signalling regulates gene activation during
development and medulloblastoma growth. Nat Commun. 5:54252014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Junker JP, Peterson KA, Nishi Y, Mao J,
McMahon AP and van Oudenaarden A: A predictive model of
bifunctional transcription factor signaling during embryonic tissue
patterning. Dev Cell. 31:448–460. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peterson KA, Nishi Y, Ma W, Vedenko A,
Shokri L, Zhang X, McFarlane M, Baizabal JM, Junker JP, van
Oudenaarden A, et al: Neural-specific Sox2 input and differential
Gli-binding affinity provide context and positional information in
Shh-directed neural patterning. Genes Dev. 26:2802–2816. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li H, Yue D, Jin JQ, Woodard GA, Tolani B,
Luh TM, Giroux-Leprieur E, Mo M, Chen Z, Che J, et al: Gli promotes
epithelial-mesenchymal transition in human lung adenocarcinomas.
Oncotarget. 7:80415–80425. 2016.PubMed/NCBI
|
|
25
|
Yauch RL, Gould SE, Scales SJ, Tang T,
Tian H, Ahn CP, Marshall D, Fu L, Januario T, Kallop D, et al: A
paracrine requirement for hedgehog signalling in cancer. Nature.
455:406–410. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang B, Fallon JF and Beachy PA:
Hedgehog-regulated processing of Gli3 produces an
anterior/posterior repressor gradient in the developing vertebrate
limb. Cell. 100:423–434. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McIntyre BAS, Ramos-Mejia V, Rampalli S,
Mechae R, Lee JH, Alev C, Sheng G and Bhatia M: Gli3-mediated
hedgehog inhibition in human pluripotent stem cells initiates and
augments developmental programming of adult hematopoiesis. Blood.
121:1543–1552. PubMed/NCBI
|
|
28
|
Rimkus TK, Carpenter RL, Qasem S, Chan M
and Lo HW: Targeting the sonic Hedgehog signaling pathway: Review
of Smoothened and GLI inhibitors. Cancers (Basel). 8. pp. E222016,
View Article : Google Scholar
|
|
29
|
Hahn H, Wicking C, Zaphiropoulous PG,
Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E,
Unden AB, Gillies S, et al: Mutations of the human homolog of
Drosophila patched in the nevoid basal cell carcinoma syndrome.
Cell. 85:841–851. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Johnson RL, Rothman AL, Xie J, Goodrich
LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr,
et al: Human homolog of patched, a candidate gene for the basal
cell nevus syndrome. Science. 272:1668–1671. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bar EE, Chaudhry A, Lin A, Fan X, Schreck
K, Matsui W, Piccirillo S, Vescovi AL, DiMeco F, Olivi A, et al:
Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like
cancer cells in glioblastoma. Stem Cells. 25:2524–2533. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Carpenter RL, Paw I, Zhu H, Sirkisoon S,
Xing F, Watabe K, Debinski W and Lo HW: The gain-of-function GLI1
transcription factor TGLI1 enhances expression of VEGF-C and TEM7
to promote glioblastoma angiogenesis. Oncotarget. 6:22653–22665.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Suzman DL and Antonarakis ES: Clinical
implications of Hedgehog pathway signaling in prostate cancer.
Cancers (Basel). 7:1983–1993. 2015. View Article : Google Scholar
|
|
34
|
Abdel-Rahman O: Hedgehog pathway
aberrations and gastric cancer; evaluation of prognostic impact and
exploration of therapeutic potentials. Tumour Biol. 36:1367–1374.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kenney AM and Rowitch DH: Sonic hedgehog
promotes G(1) cyclin expression and sustained cell cycle
progression in mammalian neuronal precursors. Mol Cell Biol.
20:9055–9067. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bigelow RL, Jen EY, Delehedde M, Chari NS
and McDonnell TJ: Sonic hedgehog induces epidermal growth factor
dependent matrix infiltration in HaCaT keratinocytes. J Invest
Dermatol. 124:457–465. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yoo YA, Kang MH, Lee HJ, Kim BH, Park JK,
Kim HK, Kim JS and Oh SC: Sonic hedgehog pathway promotes
metastasis and lymphangiogenesis via activation of Akt, EMT, and
MMP-9 pathway in gastric cancer. Cancer Res. 71:7061–7070. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Katoh Y, Katoh M and Yoo YA: Hedgehog
signaling, epithelial-to-mesenchymal transition and miRNA (Review).
Int J Mol Med. 22:271–275. 2008.PubMed/NCBI
|
|
39
|
Pantazi E, Gemenetzidis E, Teh MT, Reddy
SV, Warnes G, Evagora C, Trigiante G and Philpott MP: GLI2 is a
regulator of β-catenin and is associated with loss of E-Cadherin,
cell invasiveness, and long-term epidermal regeneration. J Invest
Dermatol. 137:1719–1730. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou M, Hou Y, Yang G, Zhang H, Tu G, Du
YE, Wen S, Xu L, Tang X, Tang S, et al: LncRNA-Hh strengthen cancer
stem cells generation in twist-positive breast cancer via
activation of Hedgehog signaling pathway. Stem Cells. 34:55–66.
2016. View Article : Google Scholar
|
|
41
|
Zhang C, Li C, He F, Cai Y and Yang H:
Identification of CD44+CD24+ gastric cancer
stem cells. J Cancer Res Clin Oncol. 137:1679–1686. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang K, Che S, Pan C, Su Z, Zheng S, Yang
S, Zhang H, Li W, Wang W and Liu J: The SHH/Gli axis regulates
CD90-mediated liver cancer stem cell function by activating the
IL6/JAK2 pathway. J Cell Mol Med. 22:3679–3690. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cavicchioli Buim ME, Gurgel CA, Gonçalves
Ramos EA, Lourenço SV and Soares FA: Activation of sonic hedgehog
signaling in oral squamous cell carcinomas: A preliminary study.
Hum Pathol. 42:1484–1490. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fan HX, Wang S, Zhao H, Liu N, Chen D, Sun
M and Zheng JH: Sonic hedgehog signaling may promote invasion and
metastasis of oral squamous cell carcinoma by activating MMP-9 and
E-cadherin expression. Med Oncol. 31:412014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schneider FT, Schänzer A, Czupalla CJ,
Thom S, Engels K, Schmidt MH, Plate KH and Liebner S: Sonic
hedgehog acts as a negative regulator of {beta}-catenin signaling
in the adult tongue epithelium. Am J Pathol. 177:404–414. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Honami T, Shimo T, Okui T, Kurio N, Hassan
NM, Iwamoto M and Sasaki A: Sonic hedgehog signaling promotes
growth of oral squamous cell carcinoma cells associated with bone
destruction. Oral Oncol. 48:49–55. 2012. View Article : Google Scholar
|
|
47
|
Mikami Y, Fujii S, Nagata K, Wada H,
Hasegawa K, Abe M, Yoshimoto RU, Kawano S, Nakamura S and Kiyoshima
T: GLI-mediated Keratin 17 expression promotes tumor cell growth
through the anti-apoptotic function in oral squamous cell
carcinomas. J Cancer Res Clin Oncol. 143:1381–1393. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
49
|
de Andrade NP, Rodrigues MF, Rodini CO and
Nunes FD: Cancer stem cell, cytokeratins and epithelial to
mesenchymal transition markers expression in oral squamous cell
carcinoma derived from ortothopic xenoimplantation of CD44high
cells. Pathol Res Pract. 213:235–244. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rodrigues MF, de Oliveira Rodini C, de
Aquino Xavier FC, Paiva KB, Severino P, Moyses RA, López RM,
DeCicco R, Rocha LA, Carvalho MB, et al: PROX1 gene is
differentially expressed in oral cancer and reduces cellular
proliferation. Medicine (Baltimore). 93:e1922014. View Article : Google Scholar
|
|
51
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM classification of malignant tumours. Wiley
Blackwell; Oxford: pp. 17–21. 2017
|
|
52
|
Schneider S, Thurnher D, Kloimstein P,
Leitner V, Petzelbauer P, Pammer J, Brunner M and Erovic BM:
Expression of the Sonic hedgehog pathway in squamous cell carcinoma
of the skin and the mucosa of the head and neck. Head Neck.
33:244–250. 2011. View Article : Google Scholar
|
|
53
|
Zöller M: CD44: Can a cancer-initiating
cell profit from an abundantly expressed molecule? Nat Rev Cancer.
11:254–267. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Williams K, Motiani K, Giridhar PV and
Kasper S: CD44 integrates signaling in normal stem cell, cancer
stem cell and (pre) metastatic niches. Exp Biol Med (Maywood).
238:324–338. 2013. View Article : Google Scholar
|
|
55
|
Ridgway J, Zhang G, Wu Y, Stawicki S,
Liang WC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I,
et al: Inhibition of Dll4 signalling inhibits tumour growth by
deregulating angiogenesis. Nature. 444:1083–1087. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhao ZL, Zhang L, Huang CF, Ma SR, Bu LL,
Liu JF, Yu GT, Liu B, Gutkind JS, Kulkarni AB, et al: NOTCH1
inhibition enhances the efficacy of conventional chemotherapeutic
agents by targeting head neck cancer stem cell. Sci Rep.
6:247042016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ishida T, Hijioka H, Kume K, Miyawaki A
and Nakamura N: Notch signaling induces EMT in OSCC cell lines in a
hypoxic environment. Oncol Lett. 6:1201–1206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yoshida R, Nagata M, Nakayama H,
Niimori-Kita K, Hassan W, Tanaka T, Shinohara M and Ito T: The
pathological significance of Notch1 in oral squamous cell
carcinoma. Lab Invest. 93:1068–1081. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Weaver AN, Burch MB, Cooper TS, Della
Manna DL, Wei S, Ojesina AI, Rosenthal EL and Yang ES: Notch
signaling activation is associated with patient mortality and
increased FGF1-mediated invasion in squamous cell carcinoma of the
oral cavity. Mol Cancer Res. 14:883–891. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Grigoryan T, Wend P, Klaus A and
Birchmeier W: Deciphering the function of canonical Wnt signals in
development and disease: Conditional loss- and gain-of-function
mutations of beta-catenin in mice. Genes Dev. 22:2308–2341. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Holland JD, Klaus A, Garratt AN and
Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr
Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Song J, Chang I, Chen Z, Kang M and Wang
CY: Characterization of side populations in HNSCC: Highly invasive,
chemoresistant and abnormal Wnt signaling. PLoS One. 5:e114562010.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Yang K, Wang X, Zhang H, Wang Z, Nan G, Li
Y, Zhang F, Mohammed MK, Haydon RC, Luu HH, et al: The evolving
roles of canonical WNT signaling in stem cells and tumorigenesis:
Implications in targeted cancer therapies. Lab Invest. 96:116–136.
2016. View Article : Google Scholar :
|
|
64
|
Aberger F: Context-dependent signal
integration by the GLI code: The oncogenic load, pathways,
modifiers and implications for cancer therapy. Semin Cell Dev Biol.
33:93–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Scales SJ and de Sauvage FJ: Mechanisms of
Hedgehog pathway activation in cancer and implications for therapy.
Trends Pharmacol Sci. 30:303–312. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Stecca B: Context-dependent regulation of
the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. J Mol
Cell Biol. 2:84–95. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Varnat F, Duquet A, Malerba M, Zbinden M,
Mas C, Gervaz P and Ruiz i Altaba A: Human colon cancer epithelial
cells harbour active HEDGEHOG-GLI signalling that is essential for
tumour growth, recurrence, metastasis and stem cell survival and
expansion. EMBO Mol Med. 1:338–351. 2009. View Article : Google Scholar
|
|
68
|
Yang N, Zhou TC, Lei XX, Wang C, Yan M,
Wang ZF, Liu W, Wang J, Ming KH, Wang BC, et al: Inhibition of
Sonic Hedgehog signaling pathway by thiazole antibiotic
thiostrepton attenuates the CD44+/CD24-stem-like
population and sphere-forming capacity in triple-negative breast
cancer. Cell Physiol Biochem. 38:1157–1170. 2016. View Article : Google Scholar
|
|
69
|
Sharma N, Nanta R, Sharma J, Gunewardena
S, Singh KP, Shankar S and Srivastava RK: PI3K/AKT/mTOR and sonic
hedgehog pathways cooperate together to inhibit human pancreatic
cancer stem cell characteristics and tumor growth. Oncotarget.
6:32039–32060. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Bora-Singhal N, Perumal D, Nguyen J and
Chellappan S: Gli1-mediated regulation of Sox2 facilitates
self-renewal of stem-like cells and confers resistance to EGFR
inhibitors in non-small cell lung cancer. Neoplasia. 17:538–551.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Sell S: Cancer stem cells and
differentiation therapy. Tumour Biol. 27:59–70. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Pattabiraman DR and Weinberg RA: Targeting
the epithelial-to-mesenchymal transition: The case for
differentiation-based therapy. Cold Spring Harb Symp Quant Biol.
81:11–19. 2016. View Article : Google Scholar
|
|
73
|
Cao L, Bombard J, Cintron K, Sheedy J,
Weetall ML and Davis TW: BMI1 as a novel target for drug discovery
in cancer. J Cell Biochem. 112:2729–2741. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Nör C, Zhang Z, Warner KA, Bernardi L,
Visioli F, Helman JI, Roesler R and Nör JE: Cisplatin induces Bmi-1
and enhances the stem cell fraction in head and neck cancer.
Neoplasia. 16:137–146. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Tsai LL, Hu FW, Lee SS, Yu CH, Yu CC and
Chang YC: Oct4 mediates tumor initiating properties in oral
squamous cell carcinomas through the regulation of
epithelial-mesenchymal transition. PLoS One. 9:e872072014.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Cai J, He B, Li X, Sun M, Lam AK, Qiao B
and Qiu W: Regulation of tumorigenesis in oral epithelial cells by
defined reprogramming factors Oct4 and Sox2. Oncol Rep. 36:651–658.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Chaffer CL, San Juan BP, Lim E and
Weinberg RA: EMT, cell plasticity and metastasis. Cancer Metastasis
Rev. 35:645–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ke Z, Caiping S, Qing Z and Xiaojing W:
Sonic hedgehog-Gli1 signals promote epithelial-mesenchymal
transition in ovarian cancer by mediating PI3K/AKT pathway. Med
Oncol. 32:3682015. View Article : Google Scholar
|
|
79
|
Rajurkar M, De Jesus-Monge WE, Driscoll
DR, Appleman VA, Huang H, Cotton JL, Klimstra DS, Zhu LJ, Simin K,
Xu L, et al: The activity of Gli transcription factors is essential
for Kras-induced pancreatic tumorigenesis. Proc Natl Acad Sci USA.
109:E1038–E1047. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Ramaswamy B, Lu Y, Teng KY, Nuovo G, Li X,
Shapiro CL and Majumder S: Hedgehog signaling is a novel
therapeutic target in tamoxifen-resistant breast cancer aberrantly
activated by PI3K/AKT pathway. Cancer Res. 72:5048–5059. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Shih CH, Chang YJ, Huang WC, Jang TH, Kung
HJ, Wang WC, Yang MH, Lin MC, Huang SF, Chou SW, et al:
EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer
metastasis. Oncogene. 36:6542–6554. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Shibue T and Weinberg RA: EMT, CSCs, and
drug resistance: The mechanistic link and clinical implications.
Nat Rev Clin Oncol. 14:611–629. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Yan M, Wang L, Zuo H, Zhang Z, Chen W, Mao
L and Zhang P: HH/GLI signalling as a new therapeutic target for
patients with oral squamous cell carcinoma. Oral Oncol. 47:504–509.
2011. View Article : Google Scholar : PubMed/NCBI
|
